A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and staphyloccocus aureus in human monocytes

Immunology

Volumn 92, Issue 3, 1997, Pages 396-401

  Kreutz, M ^a,c   Ackermann, U ^a   Hauschildt, S ^b   Krause, S W ^a   Riedel, D ^a   Bessler, W ^b   Andreesen, R ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Abt F Hamatologie and Onkologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIPOPEPTIDE; LIPOPOLYSACCHARIDE;

ANALYTIC METHOD; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MONOCYTE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STIMULUS RESPONSE;

EID: 0030693258     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00365.x     Document Type: Article

References (40)

1. FREUDENBERG M.A. & GALANOS C. (1991) Tumor necrosis factor alpha mediates lethal activily of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect Immun 59, 2110.
2. NATHAN C.F. (1987) Secretory products of macrophages. J Clin Invest 79, 319.
3. FREUDENBERG M., KEPPLER D. & GALANOS C. (1986) Requirement for lipopolysaccharide-responsive macrophages in D-galactosamine-induced sensitization to endotoxin. Infect Immun 51, 891.
4. FREUDENBERG M. & GALANOS C. (1988) Induction of tolerance to lipopolysahharide (LPS)-D-galactosamine lethality by treatment with LPS is mediated by macrophages. Infect Immun 56, 1352.
5. HOFFMANN P., HEINLE S., SCHADE U.F. et al. (1988) Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiol 177, 158.
6. HAUSCHILDT S., HOFFMANN P., BEUSCHER H.U. et al. (1990) Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur J Immunol 20, 63.
7. HAUSCHILDT S., BASSENGE E., BESSLER W., BUSSE R. & MÜLSCH A. (1990) L-arginine-dependent nitric oxide formation and nitrite release in bone-marrow-derived macrophages stimulated with bacterial lipopeptide and lipopolysaccharide. Immunology 70, 332.
8. HOFFMANN P., JUNG G., WIESMÜLLER K.-H., METZGER J. & BESSLER W.G. (1989) Induction of tumor cytotoxicity in murine bone-marrow-derived macrophages by two synthetic lipopeptide analogues. Biol Chem Hoppe-Seyler 370, 575.
9. LANDMANN R., WESP M. & DUKOR P. (1988) Modulation of interferon-gamma induced major histokompatibility (MHC) and CD14 antigen changes by muramyltripeptide (MTP-PE) in human monocytes. Cell Immunol 117, 45.
10. 2 by human blood monocytes with different bacterial derived agents. Lymphokine Res 9, 449.
11. HEUMANN D., BARRAS C., SEVERIN A., GLAUSER M.P. & TOMASZ A. (1994) Gram-positive cell walls stimulate synthesis of tumor-necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 62, 2715.
12. TIMMERMAN C.P., MATTSSON E., MARTINEZ-MARTINEZ L. et al. (1993) Induction of release of tumor-necrosis factor from monocytes by staphylococci and staphylococcal peptidoglycans. Infect Immun 61, 4167.
13. KUSUNOKI T., HAILMAN E., JUAN T.S.C., LICHENSTEIN H.S. & WRIGHT S.D. (1995) Molecules from Staphyloccocus aureus that bind CD14 and stimulate innate immune response. J Exp Med 182, 1673.
14. WEIDEMANN B., BRADE H., RIETSCHEL E.T. et al. (1994) Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun 62, 4709.
15. MATHISON J.C., VIRCA G.D., WOLFSON E., TOBIAS P.S., GLASER K. & ULEVITCH R.J. (1990) Adaption to bacterial lipopolysaccharid controls lipopolysaccharide-induced tumor-necrosis factor production in rabbit macrophages. J Clin Invest 85, 1108.
16. MATHISON J.C., WOLFSON E., STEINEMANN S., TOBIAS P. & ULEVITCH R. (1993) Lipopolysaccarid (LPS) recognition in macrophages. Participation of LPS-binding protein and CD14 in LPS-induced adaption in rabbit peritoneal exudate macrophages. J Clin Invest 92, 2053.
17. WRIGHT S.D., RAMOS R.A., TOBIAS P.S., ULEVITCH R.J. & MATHISON J.C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 249, 1431.
18. HEUMANN D., GALLAY P., BARRAS C. et al. (1992) Control of lipopolysaccharide (LPS) binding and LPS-induced tumor-necrosis factor secretion in human peripheral blood monocytes. J Immunol 148, 3505.
19. REITERMANN A., METZGER J., WIESMÜLLER K.H., JUNG G. & BESSLER W. (1989) Lipopeptide derivates of bacterial lipoprotein constitute potent immune adjuvants combined or covalently coupled to antigen or hapten. Biol Chem Hoppe-Seyler 370, 343.
20. ANDREESEN R., BRUGGER W., SCHEIBENBOGEN C. et al. (1990) Surface phenotype analysis of human monocyte to macrophage maturation. J Leuk Biol 47, 490.
21. CHOMCZYNSKI P. & SACCHI N. (1987) Single step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156.
22. CHURCH G.M. & GILBERT W. (1984) Genomic sequencing. Proc Natl Acad Sci USA 81, 1991.
23. DENTENER M.A., BAZIL V., VON ASMUTH E.J.U., CESKA M. & BUURMAN W.A. (1993) Involvement of CD 14 in lipopolysaccharide-induced tumor-necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 150, 2885.
24. 125J-LPS. Infect Immun 60, 5145.
25. CERAMI A. & BEUTLER B. (1988) The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today 9, 28.
26. SANCEAU J., FALCOFF R., BERANGER F., CARTER D.B. & WIETZERBIN J. (1990) Secretion of interleukin-6 (IL-6) by human monocytes stimulated by muramyl dipeptide and tumor necrosis factor alpha. Immunology 69, 52.
27. SCHUMANN R.R., LEONG S.R., FLAGGS G.W. et al. (1990) Structure and function of lipopolysaccharide binding protein. Science 249, 1429.
28. MATHISON J.C., TOBIAS P.S., WOLFSON E. & ULEVITCH R.J. (1992) Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J Immunol 149, 200.
29. KUSUNOKI T. & WRIGHT S.D. (1996) Chemical characteristics of Staphylococcus aureus molecules that have CD14-dependent cell stimulating activity. J Immunol 157, 5112.
30. ZUCKERMANN S.H., EVANS G.F., SNYDER Y.M. & ROEDER W.D. (1989) Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression. J Immunol 143, 1223.
31. MCCALL C.E., GROSSO-WILMOTH L.M., LARUE K., GUZMAN R.N. & COUSART S.L. (1993) Tolerance to endotoxin-induced expression of the interleukin-1ß gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 91, 853.
32. MENGOZZI M. & GHEZZI P. (1993) Cytokine down-regulation in endotoxin tolerance. Eur Cytokine Net 4, 89.
33. GRANOWITZ E.V., PORAT R., MIER J.W. et al. (1993) Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 151, 1637.
34. ZIEGLER-HEITBROCK H.W.L., BLUMENSTEIN M., KÄKEERLEIN E. et al. (1992) In vitro desensitization to lipolysaccharide suppresses tumor necrosis factor, interleukin-1 and interleukin-6 expression in a similar fashion. Immunology 75, 264.
35. CAVAILLON J.M., PITTON C. & FITTING C. (1994) Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGF-β. J Endotoxine Res 1, 21.
36. CAVAILLON J.M. (1995) The nonspecific nature of endotoxin tolerance. Trends Microbiol 3, 320.
37. ZIEGLER-HEITBROCK H.W.L., WEDEL A., SfHRAUT W. et al. (1994) Tolerance to lipopolysaccharide involves mobilization of nuclear factor KB with predominance of p50 homodimers. J Biol Chem 269, 17001.
38. LARUE K.E.A. & MCCALL C.E. (1994) A labile transcriptional repressor modulates endotoxin tolerance. J Exp Med 180, 2269.
39. BUSAM K., GIERINGER C., FREUDENBERG M. & HOHMANN H.P. (1992) Staphyloccocus aureus and derived exotoxins induce nuclear factor κB-like activity in murine bone marrow macrophages. Infect Immun 60, 2008.
40. NORGARD M.V., ARNDT L.L., AKINS D.R., CURETTY L.L., HARRICH D.A. & RADOLF J.D. (1996) Activation of human monocytic cells by Treponema pallidum and Borrrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of that of lipopolysaccharide but involves the transcritional activator NF-κB. Infect Immun 64, 3845.